Follow the Dawnrays Pharmaceutical (Holdings) Ltd. stock price and the full insider trade history of the company, a listed issuer based in Hong Kong. Shares are listed on the HK market, under the supervision of HKEX. Operating in the Health Care sector, Dawnrays Pharmaceutical (Holdings) Ltd. has recorded 17 public disclosures. Market capitalisation: €1.5bn. The latest transaction was reported on 29 June 2026 (Purchase). Among the most active insiders: Hung Yung Lai. All data is free.
17
Insider Decl.
n/a
Thresholds
€86,024
16 ops.
Buy Volume
n/a
n/a
Sell Volume
29Σ signal
Buys €86,024n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 897 of 28,717 companies
81.8
score / 100
Value
92
Quality
72
FCF yld15%
Earn yld14%
EV/EBITDA4.4x
ROE6.3%
Gross mgn50%
Net mgn17%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
84,000 shares@ HK$1.090.0006% mcap29.2% of flowShareXHKGHKEX:DA20260331E00415
17 of 17 declarations
About Dawnrays Pharmaceutical (Holdings) Ltd.
Dawnrays Pharmaceutical (Holdings) Ltd. is a company focused on the development and manufacturing of pharmaceutical products. It is listed on the Hong Kong Stock Exchange (XHKG).